Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion. - Chan EY; Lin KY; Yap DY; Ma AL (Pediatric nephrology (Berlin, Germany), 2025)